Acceleron Pharma
XLRN
#1916
Rank
A$15.47 B
Marketcap
A$253.09
Share price
0.00%
Change (1 day)
13,494.26%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: A$15.47 Billion

As of February 2026 Acceleron Pharma has a market cap of A$15.47 Billion. This makes Acceleron Pharma the world's 1916th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022A$16.06 B6.54%
2021A$15.07 B50.41%
2020A$10.02 B149.2%
2019A$4.02 B40.67%
2018A$2.85 B16.3%
2017A$2.45 B84.01%
2016A$1.33 B-40.07%
2015A$2.22 B44.42%
2014A$1.54 B22.68%
2013A$1.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$840.35 B 5,329.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$218.48 B 1,311.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$292.23 B 1,788.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$115.58 B 646.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.24 B-98.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$29.59 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$68.9 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA